The above studies suggest that as miRNAs are intensively studied in the life sciences, more and more miRNAs have been shown to mediate the developmental process of osteoporosis by affecting the differentiation, activation, and activity of OC, and these specific miRNAs may become new targets for targeted drug therapy for osteoporosis. The gene discussed is BGLAP; the disease is osteoporosis.